Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease - Archive ouverte HAL Access content directly
Journal Articles Clinics and Research in Hepatology and Gastroenterology Year : 2020

Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease

(1) , (2) , (2) , (3) , (4) , (5, 6) , (5, 7) , (5, 7) , (8) , (1, 4) , (1, 4) , (3) , (1, 4)
1
2
3
4
5
6
7
8

Abstract

Background: Haptoglobin bifucosylated tetra-antennary glycan have been identified in patients with early stage hepatocellular carcinoma, but its specificity according to the presence or not of cirrhosis has never been assessed. The aims of this study were to determine if haptoglobin bifucosylated tetra-antennary glycan (1) could be a marker of HCC in patients without cirrhosis; (2) could increase the performance of standard alpha-fetoprotein (AFP) or recent blood tests for HCC detection, i.e., lectin-reactive alpha-fetoprotein (AFP-L3), des-gamma-carboxy prothrombin (DCP) and Liver-Cancer-Risk-test (LCR1-test).Methods: We retrospectively selected patients, 102 with HCC (21 without cirrhosis), matched by stages with 140 controls without HCC (81 without cirrhosis). Haptoglobin fucosylation was assessed by MALDI-TOF. LCR-glycan algorithm was constructed combining components of the LCR-1 test (haptoglobin, gammaglutamyl-transpeptidase, apolipoproteinA1, alpha-2-macroglobulin) with AFP, AFP-L3, DCP and haptoglobin bifucosylated tetra-antennary glycan.Results: In 102 patients without cirrhosis (21 HCC and 81 controls), the intention-to-diagnose analyses showed that haptoglobin bifucosylated tetra-antennary glycan alone had a sensitivity of 71% (15/21;95%CI 50-86), significantly better (P=0.02) than standard AFP (43%;9/21;95%CI 24-63), and a specificity of 96% (78/81;95% 90-99). The sensitivity of LCR-glycan, in patients without cirrhosis, was 86% (18/21; 95%CI 63-95) significantly better (P=0.001) than standard AFP (43%; 9/21; 95%CI 24-63), with an AUROC of 0.943 (95%CI 0.806-0.98) compared to 0.811 (95%CI 0.630-0.908) for AFP (P=0.06).Conclusion: Haptoglobin bifucosylated tetra-antennary glycan is associated with the presence of HCC in patients with chronic liver disease including those without cirrhosis. Its combination with existing HCC biomarkers could improve the performance of standard AFP for HCC detection.
Fichier principal
Vignette du fichier
S2210740119302724.pdf (645.37 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03492638 , version 1 (17-10-2022)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

Valentina Peta, Jianhui Zhu, David M. Lubman, Samuel Huguet, Francoise Imbert-Bismutd, et al.. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease. Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.681 - 691. ⟨10.1016/j.clinre.2019.12.010⟩. ⟨hal-03492638⟩
14 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More